- Home
- HOTH vs ALUR Comparison
HOTH vs ALUR Comparison
Compare HOTH & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- ALUR
- Stock Information
- Founded
- HOTH 2017
- ALUR 2009
- Country
- HOTH United States
- ALUR United States
- Employees
- HOTH 3
- ALUR N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- ALUR
- Sector
- HOTH Health Care
- ALUR
- Exchange
- HOTH Nasdaq
- ALUR Nasdaq
- Market Cap
- HOTH 16.0M
- ALUR 18.0M
- IPO Year
- HOTH 2019
- ALUR N/A
- Fundamental
- Price
- HOTH $1.44
- ALUR $2.87
- Analyst Decision
- HOTH Strong Buy
- ALUR Strong Buy
- Analyst Count
- HOTH 3
- ALUR 3
- Target Price
- HOTH $4.00
- ALUR $22.83
- AVG Volume (30 Days)
- HOTH 733.2K
- ALUR 189.2K
- Earning Date
- HOTH 05-12-2025
- ALUR 08-12-2025
- Dividend Yield
- HOTH N/A
- ALUR N/A
- EPS Growth
- HOTH N/A
- ALUR N/A
- EPS
- HOTH N/A
- ALUR N/A
- Revenue
- HOTH N/A
- ALUR $28,304,000.00
- Revenue This Year
- HOTH N/A
- ALUR N/A
- Revenue Next Year
- HOTH N/A
- ALUR $49.37
- P/E Ratio
- HOTH N/A
- ALUR N/A
- Revenue Growth
- HOTH N/A
- ALUR N/A
- 52 Week Low
- HOTH $0.58
- ALUR $2.15
- 52 Week High
- HOTH $3.80
- ALUR $26.75
- Technical
- Relative Strength Index (RSI)
- HOTH 62.68
- ALUR 66.83
- Support Level
- HOTH $1.17
- ALUR $2.45
- Resistance Level
- HOTH $1.34
- ALUR $2.59
- Average True Range (ATR)
- HOTH 0.10
- ALUR 0.16
- MACD
- HOTH 0.02
- ALUR 0.06
- Stochastic Oscillator
- HOTH 77.27
- ALUR 78.57
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.